Suppr超能文献

[原发性醛固酮增多症]

[Primary hyperaldosteronism].

作者信息

Opocher G, Rocco S, Carpené G, Armanini D, Mantero F

机构信息

Istituto di Semeiotica Medica, Università degli Studi, Padova.

出版信息

Minerva Endocrinol. 1995 Mar;20(1):49-54.

PMID:7651282
Abstract

The diagnosis of primary aldosteronism (PA) is based on the finding of the combination of elevated urinary and/or plasma aldosterone and suppressed renin activity in patients with hypertension and hypokalemia. However, PA consists in a number of subsets, and diagnostic criteria for a correct identification of surgically remediable forms are of great interest. The methods and the results concerning our series of 113 patients with primary aldosteronism are presented in this review. Aldosterone producing adenoma (APA) and idiopathic hyperaldosteronism (IHA) were the most frequent forms, 51% and 44% respectively. They had similar BP levels, but hypokalemia was most frequently found in APA. Urinary and upright plasma aldosterone were similar, but supine plasma aldosterone was lower in IHA. Plasma aldosterone response to upright posture and angiotensin II infusion was absent in most cases of APA and present in IHA, but occasionally renin-responsive adenoma were found. Captopril failed to decrease plasma aldosterone in most patients with APA, and in a subgroup of patients with IHA. Patients with adenoma had also higher values of the aldosterone precursor 18-OH-B, and of atrial natriuretic peptide (ANP), probably as a consequence of a greater degree of volume expansion. Among morphological studies, CT scan and adrenal radio-cholesterol scintiscan provided similar results (85% accuracy): adrenal vein catheterization clarified almost all the remaining cases. Among the subsets of PA, 3 familiar cases of dex-suppressible hyperaldosteronism were recognized, with characteristically high levels of aldo, 18-OH-B, 18-OH-cortisol and 18-oxo-cortisol, due to the genetic abnormalities of the 11-18 hydroxylase system.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

原发性醛固酮增多症(PA)的诊断基于在高血压和低钾血症患者中发现尿和/或血浆醛固酮升高以及肾素活性受抑制。然而,PA包含多个亚组,正确识别可通过手术治愈形式的诊断标准备受关注。本综述介绍了我们对113例原发性醛固酮增多症患者的研究方法和结果。醛固酮瘤(APA)和特发性醛固酮增多症(IHA)是最常见的形式,分别占51%和44%。它们的血压水平相似,但低钾血症在APA中更为常见。尿醛固酮和立位血浆醛固酮相似,但IHA的卧位血浆醛固酮较低。大多数APA病例对立位姿势和血管紧张素II输注的血浆醛固酮反应缺失,而IHA存在该反应,但偶尔也会发现肾素反应性腺瘤。大多数APA患者以及部分IHA患者使用卡托普利后血浆醛固酮未能降低。腺瘤患者的醛固酮前体18-OH-B和心房利钠肽(ANP)值也更高,这可能是由于容量扩张程度更大所致。在形态学研究中,CT扫描和肾上腺放射性胆固醇闪烁扫描结果相似(准确率85%):肾上腺静脉插管几乎能明确其余所有病例。在PA的亚组中,识别出3例家族性地塞米松可抑制性醛固酮增多症病例,其醛固酮、18-OH-B、18-OH-皮质醇和18-氧代皮质醇水平特征性升高,这是由于11-18羟化酶系统的基因异常所致。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验